Gastroenterology and Inflammatory Bowel Disease
Faes Farma S.A. supports clinical research in ulcerative colitis and chronic idiopathic inflammatory bowel disease, with attention to symptoms, intestinal inflammation, and remission outcomes in patients with active disease.
- Ulcerative colitis
- Clinical remission
- Mesalazine
The sponsor’s gastrointestinal portfolio also includes studies in oral mesalazine formulations and their use in controlling disease activity.
Allergy and Respiratory Immunology
Another major area of interest is allergic rhinoconjunctivitis and broader allergy care, including research on symptom relief, ocular and nasal manifestations, and treatment response in both adults and children.
- Allergic rhinoconjunctivitis
- Antihistamine therapy
- Pediatric allergy
Trials in this field examine oral allergy medicines such as bilastine, ebastine, and desloratadine.
Clinical Pharmacology in Healthy Volunteers
Faes Farma S.A. also funds pharmacokinetic research in healthy volunteers, focusing on how oral medicines are absorbed and handled by the body under fasting and fed conditions.
- Pharmacokinetics
- Bioequivalence
- Healthy volunteers
These studies include comparisons of oral formulations for medicines such as dexketoprofen, mesalazine, and alendronic acid.
Bone and Musculoskeletal Therapeutics
The sponsor’s research landscape extends to alendronic acid formulations, reflecting interest in therapies used in bone health and related musculoskeletal treatment settings.
- Alendronic acid
- Oral formulations
- Bioavailability
Work in this area is centered on oral delivery and comparative performance of formulations in healthy subjects.
